Effects of monoamine reuptake inhibitors on wet-dog shakes mediated by 5-HT2A receptors in ACTH-treated rats.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  2005-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.PBB.2005.02.010PMID 15894065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HT2 receptor binding sites in neocortex of rat forebrain and 5-HT2 receptor-mediated wet-dog shake behaviors

  2005cited by this paper
• Effect of chronic administration of antidepressant drugs on 5-HT2-mediated behavior in the rat following noradrenergic or serotonergic denervation

  2005cited by this paper
• Inhibition of head twitch response to quipazine in rats by chronic amitriptyline but not fluvoxamine or citalopram

  2004cited by this paper
• Effects of imipramine and lithium on wet-dog shakes mediated by the 5-HT2A receptor in ACTH-treated rats.

  2002cited by this paper
• Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats.

  1997cited by this paper
• Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter.

  1996cited by this paper
• Bupropion: a review of its mechanism of antidepressant activity.

  1995cited by this paper
• Chronic fluoxetine or desmethylimipramine treatment alters 5-HT2 receptor mediated c-fos gene expression.

  1995cited by this paper
• Pharmacological properties of a new antidepressant, fluvoxamine (SME3110): Effects on extracellular levels of monomine in vivo and monoaminergic receptors in rat brain.

  1994cited by this paper
• Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI).

  1993cited by this paper
• Evidence that chronic administration of paroxetine or fluoxetine enhances 5-HT2 receptor function in the brain of the guinea pig.

  1993cited by this paper
• Regulation of serotonin type 2 (5-HT2) and beta-adrenergic receptors in rat cerebral cortex following novel and classical antidepressant treatment.

  1991cited by this paper
• Binding and function of serotonin 2 receptors following chronic administration of imipramine.

  1984cited by this paper
• Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.

  1983cited by this paper
• Fluvoxamine, a new antidepressant drug, fails to show antiserotonin activity.

  1982cited by this paper
• Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding.

  1980cited by this paper
• Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline.

  1980cited by this paper
• Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment.

  1979cited by this paper
• Mazindol and amphetamine as inhibitors of the uptake and releasers of 3H-dopamine by rat striatal synaptosomes

  1977cited by this paper
• "Wet-dog" shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity.

  1977cited by this paper
• Studies on the capacity of mazindol and dita to act as uptake inhibitors or releasing agents for 3H-biogenic amines in rat brain tissue slices.

  1977cited by this paper

• Influence of 5-HT2A receptor function on anxiety-like behavior induced by a combination treatment with doxorubicin and cyclophosphamide in rats

  2021cites this paper
• Orexin 2 Receptor Antagonists from Prefrontal Cortical Circuitry to Rodent Behavioral Screens

  2019cites this paper
• Experimental occlusal disharmony – A promoting factor for anxiety in rats under chronic psychological stress

  2017cites this paper
• New Findings on the Sensitivity of Free-Operant Timing Behaviour to 5-Hydroxytryptamine Receptor Stimulation

  2014cites this paper
• L’amphétamine intra-habenulaire n’altère pas l’effet de récompense induit par la stimulation électrique du raphé dorsal

  2012cites this paper
• Chronic coadministration of carbamazepine together with imipramine produces antidepressant-like effects in an ACTH-induced animal model of treatment-resistant depression: involvement of 5-HT(2A) receptors?

  2008cites this paper
• Effects of imipramine and bupropion on the duration of immobility of ACTH-treated rats in the forced swim test: involvement of the expression of 5-HT2A receptor mRNA.

  2008cites this paper
• Increased DOI-induced wet-dog shakes in adrenocorticotropic hormone-treated rats are not affected by chronic imipramine treatment: possible involvement of enhanced 5-HT(2A)-receptor expression in the frontal cortex.

  2008cites this paper
• The Influence of hyperactivity of the hypothalamic-pituitary-adrenal axis and hyperglycemia on the 5-HT2A receptor-mediated wet-dog shake responses in rats.

  2007cites this paper
• Effects of physical and psychological stress on 5-HT2A receptor-mediated wet-dog shake responses in streptozotocin-induced diabetic rats.

  2007cites this paper
• [Strategy to develop a new drug for treatment-resistant depression--role of electroconvulsive stimuli and BDNF].

  2007cites this paper
• Role of atypical opiates in OCD. Experimental approach through the study of 5-HT2A/C receptor-mediated behavior

  2006cites this paper